Among 250 cases with history of AMLs, 23.64% vs. 34.25% vs. 66.22% patients had AMLs with a diameter of the largest tumor 3 cm or more in VEGF-D non-elevated group, mildly-elevated and highly-elevated group respectively. This evidence concerns the gene VEGFD and neoplasm.